Methotrexate 2.5 mg Tablets Unit Carton Label (Image 01)
Methotrexate Tablet
Product Images NDC 51079-670
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Methotrexate (NDC 51079-670). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mylan Institutional Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Unit Carton (Image 02)
This is a description of a medication called Methotrexate in tablet form. The tablets are a cytotoxic agent and require caution. The tablets come in a bottle of 20 and contain 2.5g of Methotrexate equivalent to 2.74mg of Methotreat sodium per tablet. The recommended dosage is unknown and instructions should be provided by a prescribing health professional. The tablets should be stored between 20°C to 25°C and protected from light. They are manufactured by Mylan Pharmaceuticals, located in Morgantown, USA.*
Image 03
This text contains important information regarding a medication packaging unit. It indicates that this package is not child resistant and should only be used by institutions or adults. It is important to keep this container and all medications out of reach of children. Additionally, it provides light-resistance for the enclosed medication. The packaging also features a window where the lot number and expiration date can be found. The manufacturer of this product is Mylan and the physical address is located in Rockford, USA.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
